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BACKGROUND
•  COPA syndrome is a newly discovered 
hereditary immune dysregulatory primary 
immunodeficiency which is autosomal 
dominant with variable penetrance.1,2
•  The mutated gene, COPA, encodes the alpha 
subunit of the coatomer complex-I which is 
involved in the transit of proteins between the 
Golgi complex and endoplasmic reticulum.1–3
•  Most commonly presents before the age of 5 
with a female predominance.1,3
•  Early symptoms include shortness of breath, 
cough, and joint pain.1,2
CLINICAL FEATURES PREVALENCE
Pulmonary Hemorrhage High 
Interstitial Lung Disease Moderate 
Renal Disease Very High 
Arthritis High 
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CASE DESCRIPTION
55-year-old female with a past medical history of chronic cavitary 
aspergillosis status post three lung resections, pulmonary 
hemorrhage, undifferentiated connective tissue disease, adrenal 
insufficiency, and recurrent squamous cell carcinoma presented 
for evaluation of immunodeficiency due to unusual and recurrent 
pulmonary infections (aspergillosis and mycoplasma). Physical 
exam was remarkable for a left forehead scar and nose lesion 
being worked up for squamous cell cancer. Her significant 
medications included posaconazole and previously voriconazole.
RESULTS
•  Negative: Rheumatoid factor (RF), cyclic citrullinated peptide 
(CCP), anti-nuclear antibodies, anti-myeloperoxidase (MPO) 
and anti-proteinase 3 (PR3) antibodies.
•  Buccal Biospy: Negative for Sjogren’s Disease.
•  CT Chest: multiple thick-walled cystic lesions consistent with 
aspergillosis and scattered ground glass opacities  bilaterally. 
•  COPA Gene: Positive in July 2016.
DISCUSSION
•  Our case highlights the findings of recurrent cavitary 
aspergillosis and recurrent skin cancers in COPA 
syndrome. 
•  COPA syndrome may be more common than other 
primary immunodeficiencies due to being autosomal 
dominant.1
•  While COPA syndrome should always been considered  
in young patients with pulmonary disease, it is also 
important to recognize different presentations and 
consider undiagnosed COPA syndrome in adults with 
suspected immunodeficiency.2
•  When suspected, patients should be tested for COPA 
gene mutation to allow for further development of 
diagnostic criteria and treatment regimens. 
